TWST - twistbioscience.com Company Value to Earnings Growth Ratio

Symbol and logo of brand Twist Bioscience (TWST)

Twist Bioscience (TWST) is expanding its presence by integrating its platforms with pharmaceutical industry behemoths. The history of P/E to growth rate ratios confirms this trajectory, with the indicator value standing at 0.00. Order stability is ensured by the deep integration of DNA synthesis into R&D processes, although fierce competition in the biotech sector creates risks of price dumping for genes.

TWST: Twist Bioscience Inc PEG Multiple 07/04/2022 - 11/10/2026
Core merchandise of Twist Bio

For Twist Bioscience (TWST), which operates in the stable, non-cyclical synthetic DNA sector, this indicator allows for an assessment of capitalization efficiency driven by technological leadership and synthesis optimization. By analyzing the PEG ratio, an investor correlates market value with earnings growth: a value below one signals that the business is undervalued relative to its expansion.

Competing companies

Growth-Adjusted Market Cap to Net Income Tempus AI, Inc|Qiagen Group - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio IONS (Isis Pharmaceuticals)|RGEN: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio RNA (aviditybiosciences.com)|CRSP: PEG Multiple|WGS (GeneDx Holdings) - Price/Earnings to Growth Ratio|RARE (Ultragenyx Pharma) - PEG Multiple|Beam Tx (BEAM) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Sarepta Therapeutics, Inc. (SRPT)|TXG - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Intellia Therapeutics, Inc. NTLA|Growth-Adjusted Market Cap to Net Income Stoke Therapeutics Inc (STOK)|BioLife Corp - PEG Multiple|Wave Pharma (WVE) - Price/Earnings to Growth Multiple|MAZE: PEG Multiple|SION - Growth-Adjusted Market Cap to Net Income|PRME (Prime Medicine) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Taysha Gene Therapies Inc TSHA|Price/Earnings to Growth Ratio uniQure Corp (QURE)|MeiraGTx Corp - Growth-Adjusted P/E Ratio|PEG Multiple RGNX (REGENXBIO Inc.)|SLDB - Price/Earnings to Growth Multiple|Ocugen - PEG Multiple|Price to Earnings Adjusted for Growth Rate Pacific Biosciences of California, Inc.|BNTC (Benitec) - Price/Earnings to Growth Multiple|DSGN: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple RCKT|Price/Earnings to Growth Multiple 4dmoleculartherapeutics.com (FDMT)|Price/Earnings to Growth Ratio Lexeo Therapeutics (LXEO)|Growth-Adjusted Market Cap to Net Income korrobio.com|Editas - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio SLN (Silence Therapeutics Corp)|ProQR Therapeutics NV - PEG Multiple|CDXS (Codexis, Inc.) - Growth-Adjusted P/E Ratio|Sangamo Therapeutics, Inc. (SGMO) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio NAUT|MGX (Metagenomi, Inc) - PEG Multiple|PEG Multiple Precision BioSciences Inc.|Price/Earnings to Growth Multiple GBIO (Generation Bio Co.)|Company Value to Earnings Growth Ratio BOLD|Exicure - Price/Earnings to Growth Multiple|IMNN - Price/Earnings to Growth Multiple|RXi Pharmaceuticals - PEG Multiple|Growth-Adjusted Market Cap to Net Income Mustang Bio, Inc. MBIO|transcodetherapeutics.com (RNAZ) - Price/Earnings to Growth Ratio|BNGO - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple APDN|BLUE (bluebird bio Inc.) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple IPA (ImmunoPrecise Antibodies)|OMGA (Omega Therapeutics Corp) - Growth-Adjusted Payback Ratio|PEG Multiple OMIC (Singular Genomics Systems)|regulusrx.com - Price/Earnings to Growth Ratio|Syros Pharmaceuticals, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Telesis Bio Inc. TBIO|TRACON (TCON) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Unity Biotechnology, Inc (UBX)